Orthosis DCFzO in Charcot Neuroarthropathy Management

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 2226-PUB
Author(s):  
JULIUS N. IMMANUEL
Keyword(s):  
Charcot Neuroarthropathy

Investigating the Use of Prolia (Denosumab) in the Treatment of Acute Charcot Neuroarthropathy

2020 ◽  
Author(s):  
David Shofler ◽  
Elnaz Hamedani ◽  
Jonathan Seun ◽  
Airani Sathananthan ◽  
Emmanuel Katsaros ◽  
...  
Keyword(s):  
Charcot Neuroarthropathy

Association between Osteoprotegerin and Charcot Neuroarthropathy: a systematic review

2021 ◽  
Author(s):  
Renata Ochoa-Précoma ◽  
Blanca T. Pacheco-Soto ◽  
Leonardo M. Porchia ◽  
Enrique Torres-Rasgado ◽  
Ricardo Pérez-Fuentes ◽  
...  
Keyword(s):  
Systematic Review ◽  
Charcot Neuroarthropathy

scholarly journals Rare case of distal tibial Diffuse Large B-cell Lymphoma (DLBCL) in a Diabetic with Charcot Neuroarthropathy

2021 ◽  
pp. 100045
Author(s):  
Resident Physician Trevor Klinkner ◽  
Margaret Kerins ◽  
Devrie Stellar ◽  
Corine Creech ◽  
Richard Derner
Keyword(s):  
B Cell ◽  
Rare Case ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Charcot Neuroarthropathy ◽  
Large B Cell Lymphoma ◽  
Large B Cell

scholarly journals The Role of Bone Scintigraphy with SPECT/CT in the Characterization and Early Diagnosis of Stage 0 Charcot Neuroarthropathy

2020 ◽  
Vol 9 (12) ◽  
pp. 4123
Author(s):  
Raju Ahluwalia ◽  
Ahmad Bilal ◽  
Nina Petrova ◽  
Krishna Boddhu ◽  
Chris Manu ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Early Diagnosis ◽  
Bone Scintigraphy ◽  
Photon Emission ◽  
Emission Computed Tomography ◽  
Charcot Foot ◽  
Bone Pathology ◽  
Charcot Neuroarthropathy ◽  
Focal Uptake ◽  
Stage 1

We describe the use of Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) in the investigation and diagnosis of Charcot neuroarthropathy (CN) in patients with a hot swollen foot but normal radiographs and clinical suspicion of CN, usually termed Stage 0. This was a retrospective cohort review of 46 diabetes patients who underwent 3 phase bone scintigraphy with “High Resolution” SPECT/CT. The imaging demonstrated that Stage 0 Charcot foot has a distinct bone pathology, which can be classified into three groups: (1) fractures on Computed Tomography (CT) with accompanying focal uptake of tracer on SPECT, (2) bony abnormalities apart from fracture on CT with focal uptake of tracer on SPECT, and (3) normal CT but focal bony uptake of tracer on SPECT. The CT component of SPECT/CT detected bony fractures in 59% of patients. Early treatment with below knee cast and follow-up for 24 months showed only 4 patients who developed Stage 1 Eichenholtz Charcot foot. Our findings support the use of 3 phase bone scintigraphy with SPECT/CT in the characterization and early diagnosis of CN. Stage 0 Charcot foot has a distinct bone pathology which requires urgent treatment to prevent progression to Stage 1 Eichenholtz Charcot foot. If SPECT/CT is unavailable, CT alone will detect bone fracture in 59% patients.

Charcot Neuroarthropathy

2017 ◽  
pp. 419-421
Author(s):  
Megan N. Severson ◽  
Michael D. Johnson
Keyword(s):  
Charcot Neuroarthropathy

Charcot neuroarthropathy triggered by osteomyelitis and/or surgery

2008 ◽  
Vol 25 (12) ◽  
pp. 1469-1472 ◽  
Author(s):  
A. Ndip ◽  
E. B. Jude ◽  
R. Whitehouse ◽  
M. Prescott ◽  
A. J. Boulton
Keyword(s):  
Charcot Neuroarthropathy

Lengthen, Alignment, and Beam Technique for Midfoot Charcot Neuroarthropathy

2018 ◽  
Vol 35 (4) ◽  
pp. 497-507 ◽  
Author(s):  
Guido A. LaPorta ◽  
Alison D’Andelet
Keyword(s):  
Charcot Neuroarthropathy ◽  
Beam Technique

scholarly journals NEMISIS Minimally Invasive Surgical Correction for Midfoot Charcot Arthropathy

2018 ◽  
Vol 3 (3) ◽  
pp. 2473011418S0035 ◽  
Author(s):  
Roslyn Miller
Keyword(s):  
Surgical Technique ◽  
Minimally Invasive ◽  
Revision Surgery ◽  
Soft Tissues ◽  
Significant Risk ◽  
Wedge Osteotomy ◽  
Charcot Neuroarthropathy ◽  
Minimally Invasive Surgical ◽  
Wound Breakdown ◽  
Hind Foot

Category: Diabetes Introduction/Purpose: The most common cause of Charcot Neuroarthropathy is diabetes. The incidence of diabetes continues to rise globally, with a significant socio-economic burden to both patient and society. Despite good total contact casting techniques, deformity and subsequent ulceration still occurs in this patient group. This make shoe-fitting challenging and the risk of subsequent ulceration increases. This in-turn increases the patients risk of amputation and mortality at five years. Conservative treatment is often protracted, with multiple clinic visits. The has a significant impact on the patients ability to work and quality of life. Open surgery carries a significant risk of poor wound healing and infection again with risk of ulceration. NEMISIS for mid-foot Charcot provides surgeons with a surgical technique for osteotomy, that protects the soft tissues. Methods: The surgical technique utilises Minimally Invasive Shanon and Wedge burrs to perform a biplanar closing wedge osteotomy to achieve a triplanar correction. This takes the tension off the soft tissues which ensures that there is still good tissue cover, without compromising the blood supply to the skin, therefore in theory reducing the risk of infection. Stabilisation is achieved with screws, beams and bolts, +/-medial column plating. Patients are immobilised in a Bholer walker for a period of 3 months post-op. The short to medium term results (3months to 3 years) are presented. Patients are followed up to asses for re-ulceration at the same site, different site, failure of metalwork, return to surgery. Results: 16 patients were followed-up. 14 were diabetics. 4 patients developed deep-seated infection, which required removal of the metal-work. 2 of these patients did not have recurrence of their deformity and progressed to orthotic foot-wear. 1 patient had recurrence of deformity with wound breakdown and is awaiting further surgery. 1 patient had removal of metalwork from midfoot and subsequently developed hind-foot deformity which was stabilised with a hind-foot fusion nail. 1 patient broke the medial beam and bolts and required revision surgery. 2 patients had recurrence of plantar exostosis which was managed with minimally invasive exostectomy. 1 patient had early stabilisation of mid-foot and had subsequent Charcot of the talus, managed conservatively. The remaining patients have not required revision surgery. There have been not amputations. Conclusion: NEMISIS Minimally Invasive Surgery for Mid-Foot Charcot is a promising surgical technique which may help to reduce infection rates and subsequent amputations. The technique is relatively straightforward to teach, but is currently limited by the size of the burrs. The technique however can be coupled with innovation in biologics to aid the surgeon further in trying to achieve a stable plantigrade foot that does not have recurrence of ulceration and deformity.

Osteopenia, Neurological Dysfunction, and the Development of Charcot Neuroarthropathy

Diabetes Care ◽  
1995 ◽  
Vol 18 (1) ◽  
pp. 34-38 ◽  
Author(s):  
M. J. Young ◽  
A. Marshall ◽  
J. E. Adams ◽  
P. L. Selby ◽  
A. J. Boulton
Keyword(s):  
Neurological Dysfunction ◽  
Charcot Neuroarthropathy
Sign in / Sign up

Export Citation Format

Share Document